Logo image of LEN

LENNAR CORP-A (LEN) Stock Fundamental Analysis

USA - NYSE:LEN - US5260571048 - Common Stock

126.04 USD
+2.02 (+1.63%)
Last: 9/26/2025, 8:06:47 PM
126.35 USD
+0.31 (+0.25%)
After Hours: 9/26/2025, 8:06:47 PM
Fundamental Rating

6

LEN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 63 industry peers in the Household Durables industry. LEN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

LEN had positive earnings in the past year.
LEN had a positive operating cash flow in the past year.
LEN had positive earnings in each of the past 5 years.
LEN had a positive operating cash flow in each of the past 5 years.
LEN Yearly Net Income VS EBIT VS OCF VS FCFLEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

LEN has a better Return On Assets (9.38%) than 74.60% of its industry peers.
Looking at the Return On Equity, with a value of 14.28%, LEN is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
LEN has a Return On Invested Capital of 10.16%. This is in the better half of the industry: LEN outperforms 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LEN is above the industry average of 10.52%.
Industry RankSector Rank
ROA 9.38%
ROE 14.28%
ROIC 10.16%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.81%
ROIC(5y)12.14%
LEN Yearly ROA, ROE, ROICLEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of LEN (9.11%) is better than 76.19% of its industry peers.
In the last couple of years the Profit Margin of LEN has grown nicely.
LEN's Operating Margin of 12.14% is fine compared to the rest of the industry. LEN outperforms 77.78% of its industry peers.
LEN's Operating Margin has improved in the last couple of years.
LEN has a Gross Margin of 13.73%. This is amonst the worse of the industry: LEN underperforms 93.65% of its industry peers.
LEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.14%
PM (TTM) 9.11%
GM 13.73%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
LEN Yearly Profit, Operating, Gross MarginsLEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

7

2. Health

2.1 Basic Checks

LEN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, LEN has less shares outstanding
Compared to 5 years ago, LEN has less shares outstanding
The debt/assets ratio for LEN has been reduced compared to a year ago.
LEN Yearly Shares OutstandingLEN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
LEN Yearly Total Debt VS Total AssetsLEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

LEN has an Altman-Z score of 4.45. This indicates that LEN is financially healthy and has little risk of bankruptcy at the moment.
LEN has a better Altman-Z score (4.45) than 76.19% of its industry peers.
The Debt to FCF ratio of LEN is 15.73, which is on the high side as it means it would take LEN, 15.73 years of fcf income to pay off all of its debts.
LEN has a Debt to FCF ratio (15.73) which is in line with its industry peers.
LEN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
LEN's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. LEN outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 15.73
Altman-Z 4.45
ROIC/WACC1.17
WACC8.69%
LEN Yearly LT Debt VS Equity VS FCFLEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

A Current Ratio of 7.62 indicates that LEN has no problem at all paying its short term obligations.
LEN's Current ratio of 7.62 is amongst the best of the industry. LEN outperforms 82.54% of its industry peers.
A Quick Ratio of 1.02 indicates that LEN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.02, LEN perfoms like the industry average, outperforming 49.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.62
Quick Ratio 1.02
LEN Yearly Current Assets VS Current LiabilitesLEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

4

3. Growth

3.1 Past

The earnings per share for LEN have decreased strongly by -34.90% in the last year.
The Earnings Per Share has been growing by 20.01% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 3.53% in the past year.
LEN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.75% yearly.
EPS 1Y (TTM)-34.9%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-53.05%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%-6.43%

3.2 Future

The Earnings Per Share is expected to grow by 9.89% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.30% on average over the next years.
EPS Next Y-39.42%
EPS Next 2Y-18.3%
EPS Next 3Y-5.04%
EPS Next 5Y9.89%
Revenue Next Year-1.17%
Revenue Next 2Y0.36%
Revenue Next 3Y2.05%
Revenue Next 5Y5.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LEN Yearly Revenue VS EstimatesLEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
LEN Yearly EPS VS EstimatesLEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.82, LEN is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of LEN is on the same level as its industry peers.
LEN is valuated cheaply when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.17, the valuation of LEN can be described as correct.
LEN's Price/Forward Earnings is on the same level as the industry average.
LEN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.89.
Industry RankSector Rank
PE 12.82
Fwd PE 13.17
LEN Price Earnings VS Forward Price EarningsLEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LEN's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as LEN.
Industry RankSector Rank
P/FCF 117.15
EV/EBITDA 8
LEN Per share dataLEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

The decent profitability rating of LEN may justify a higher PE ratio.
LEN's earnings are expected to decrease with -5.04% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.64
EPS Next 2Y-18.3%
EPS Next 3Y-5.04%

6

5. Dividend

5.1 Amount

LEN has a Yearly Dividend Yield of 1.61%.
Compared to an average industry Dividend Yield of 2.65, LEN pays a bit more dividend than its industry peers.
LEN's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

On average, the dividend of LEN grows each year by 65.54%, which is quite nice.
LEN has paid a dividend for at least 10 years, which is a reliable track record.
LEN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)65.54%
Div Incr Years1
Div Non Decr Years15
LEN Yearly Dividends per shareLEN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

LEN pays out 16.62% of its income as dividend. This is a sustainable payout ratio.
The dividend of LEN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP16.62%
EPS Next 2Y-18.3%
EPS Next 3Y-5.04%
LEN Yearly Income VS Free CF VS DividendLEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B
LEN Dividend Payout.LEN Dividend Payout, showing the Payout Ratio.LEN Dividend Payout.PayoutRetained Earnings

LENNAR CORP-A

NYSE:LEN (9/26/2025, 8:06:47 PM)

After market: 126.35 +0.31 (+0.25%)

126.04

+2.02 (+1.63%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)09-18 2025-09-18/amc
Earnings (Next)12-16 2025-12-16/amc
Inst Owners97.43%
Inst Owner Change3.08%
Ins Owners1.8%
Ins Owner Change1.05%
Market Cap32.65B
Analysts69.17
Price Target128.77 (2.17%)
Short Float %5.35%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend2
Dividend Growth(5Y)65.54%
DP16.62%
Div Incr Years1
Div Non Decr Years15
Ex-Date07-03 2025-07-03 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.08%
Min EPS beat(2)-7.71%
Max EPS beat(2)11.86%
EPS beat(4)2
Avg EPS beat(4)4.24%
Min EPS beat(4)-7.71%
Max EPS beat(4)16.11%
EPS beat(8)6
Avg EPS beat(8)6.35%
EPS beat(12)9
Avg EPS beat(12)9.02%
EPS beat(16)11
Avg EPS beat(16)7.19%
Revenue beat(2)2
Avg Revenue beat(2)1.66%
Min Revenue beat(2)1.66%
Max Revenue beat(2)1.66%
Revenue beat(4)3
Avg Revenue beat(4)0.66%
Min Revenue beat(4)-2.32%
Max Revenue beat(4)1.66%
Revenue beat(8)6
Avg Revenue beat(8)1.37%
Revenue beat(12)8
Avg Revenue beat(12)2.36%
Revenue beat(16)12
Avg Revenue beat(16)2.02%
PT rev (1m)2.24%
PT rev (3m)-6.91%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)-24.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-14.6%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-6.06%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-1.81%
Valuation
Industry RankSector Rank
PE 12.82
Fwd PE 13.17
P/S 0.92
P/FCF 117.15
P/OCF 79.68
P/B 1.45
P/tB 1.71
EV/EBITDA 8
EPS(TTM)9.83
EY7.8%
EPS(NY)9.57
Fwd EY7.6%
FCF(TTM)1.08
FCFY0.85%
OCF(TTM)1.58
OCFY1.25%
SpS136.57
BVpS87.17
TBVpS73.88
PEG (NY)N/A
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 9.38%
ROE 14.28%
ROCE 13.31%
ROIC 10.16%
ROICexc 10.54%
ROICexgc 20.97%
OM 12.14%
PM (TTM) 9.11%
GM 13.73%
FCFM 0.79%
ROA(3y)10.45%
ROA(5y)10.53%
ROE(3y)15.85%
ROE(5y)16.42%
ROIC(3y)12.81%
ROIC(5y)12.14%
ROICexc(3y)15.1%
ROICexc(5y)13.98%
ROICexgc(3y)19.12%
ROICexgc(5y)17.25%
ROCE(3y)16.78%
ROCE(5y)15.9%
ROICexcg growth 3Y-0.73%
ROICexcg growth 5Y10.92%
ROICexc growth 3Y-5.57%
ROICexc growth 5Y8.18%
OM growth 3Y-10.07%
OM growth 5Y2.56%
PM growth 3Y-12.02%
PM growth 5Y5.94%
GM growth 3Y-8.58%
GM growth 5Y3%
F-Score4
Asset Turnover1.03
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 15.73
Debt/EBITDA 0.99
Cap/Depr 104.87%
Cap/Sales 0.37%
Interest Coverage 250
Cash Conversion 9.27%
Profit Quality 8.64%
Current Ratio 7.62
Quick Ratio 1.02
Altman-Z 4.45
F-Score4
WACC8.69%
ROIC/WACC1.17
Cap/Depr(3y)101.58%
Cap/Depr(5y)91.5%
Cap/Sales(3y)0.32%
Cap/Sales(5y)0.3%
Profit Quality(3y)86.08%
Profit Quality(5y)96.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-34.9%
EPS 3Y3.67%
EPS 5Y20.01%
EPS Q2Q%-53.05%
EPS Next Y-39.42%
EPS Next 2Y-18.3%
EPS Next 3Y-5.04%
EPS Next 5Y9.89%
Revenue 1Y (TTM)3.53%
Revenue growth 3Y9.32%
Revenue growth 5Y9.75%
Sales Q2Q%-6.43%
Revenue Next Year-1.17%
Revenue Next 2Y0.36%
Revenue Next 3Y2.05%
Revenue Next 5Y5.3%
EBIT growth 1Y-26.49%
EBIT growth 3Y-1.69%
EBIT growth 5Y12.56%
EBIT Next Year-37.95%
EBIT Next 3Y-7.95%
EBIT Next 5Y4.38%
FCF growth 1Y-94.16%
FCF growth 3Y-3.29%
FCF growth 5Y9.84%
OCF growth 1Y-91.56%
OCF growth 3Y-1.73%
OCF growth 5Y10.15%